These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8239565)

  • 21. Relationship between visual hallucinations and REM sleep behavior disorder in patients with Parkinson's disease.
    Meral H; Aydemir T; Ozer F; Ozturk O; Ozben S; Erol C; Cetin S; Hanoglu L; Ozkayran T; Yilsen M
    Clin Neurol Neurosurg; 2007 Dec; 109(10):862-7. PubMed ID: 17913346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual hallucinations in Parkinson's disease: clues to separate origins.
    Onofrj M; Bonanni L; Albani G; Mauro A; Bulla D; Thomas A
    J Neurol Sci; 2006 Oct; 248(1-2):143-50. PubMed ID: 16806269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian rest-activity rhythm is altered in Parkinson's disease patients with hallucinations.
    Whitehead DL; Davies AD; Playfer JR; Turnbull CJ
    Mov Disord; 2008 Jun; 23(8):1137-45. PubMed ID: 18442142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
    Holloway RG; Shoulson I; Fahn S; Kieburtz K; Lang A; Marek K; McDermott M; Seibyl J; Weiner W; Musch B; Kamp C; Welsh M; Shinaman A; Pahwa R; Barclay L; Hubble J; LeWitt P; Miyasaki J; Suchowersky O; Stacy M; Russell DS; Ford B; Hammerstad J; Riley D; Standaert D; Wooten F; Factor S; Jankovic J; Atassi F; Kurlan R; Panisset M; Rajput A; Rodnitzky R; Shults C; Petsinger G; Waters C; Pfeiffer R; Biglan K; Borchert L; Montgomery A; Sutherland L; Weeks C; DeAngelis M; Sime E; Wood S; Pantella C; Harrigan M; Fussell B; Dillon S; Alexander-Brown B; Rainey P; Tennis M; Rost-Ruffner E; Brown D; Evans S; Berry D; Hall J; Shirley T; Dobson J; Fontaine D; Pfeiffer B; Brocht A; Bennett S; Daigneault S; Hodgeman K; O'Connell C; Ross T; Richard K; Watts A;
    Arch Neurol; 2004 Jul; 61(7):1044-53. PubMed ID: 15262734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoration of normal motor control in Parkinson's disease during REM sleep.
    De Cock VC; Vidailhet M; Leu S; Texeira A; Apartis E; Elbaz A; Roze E; Willer JC; Derenne JP; Agid Y; Arnulf I
    Brain; 2007 Feb; 130(Pt 2):450-6. PubMed ID: 17235126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High doses of pergolide improve clinical global impression in advanced Parkinson's disease:- a preliminary open label study.
    Arnold G; Gasser T; Storch A; Lipp A; Kupsch A; Hundemer HP; Schwarz J
    Arch Gerontol Geriatr; 2005; 41(3):239-53. PubMed ID: 16029905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hallucinations and REM sleep behaviour disorder in Parkinson's disease: dream imagery intrusions and other hypotheses.
    Manni R; Terzaghi M; Ratti PL; Repetto A; Zangaglia R; Pacchetti C
    Conscious Cogn; 2011 Dec; 20(4):1021-6. PubMed ID: 21071244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hallucinations and sleep-wake cycle in Alzheimer's disease: a questionnaire-based study in 218 patients.
    Sinforiani E; Terzaghi M; Pasotti C; Zucchella C; Zambrelli E; Manni R
    Neurol Sci; 2007 Apr; 28(2):96-9. PubMed ID: 17464473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
    Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poor visual discrimination and visual hallucinations in Parkinson's disease.
    Diederich NJ; Goetz CG; Raman R; Pappert EJ; Leurgans S; Piery V
    Clin Neuropharmacol; 1998; 21(5):289-95. PubMed ID: 9789709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.
    Storch A; Trenkwalder C; Oehlwein C; Winkelmann J; Polzer U; Hundemer HP; Schwarz J
    Parkinsonism Relat Disord; 2005 Sep; 11(6):393-8. PubMed ID: 15993640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis.
    Arnulf I; Bonnet AM; Damier P; Bejjani BP; Seilhean D; Derenne JP; Agid Y
    Neurology; 2000 Jul; 55(2):281-8. PubMed ID: 10908906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sleepiness in Parkinson's disease: a controlled study.
    Brodsky MA; Godbold J; Roth T; Olanow CW
    Mov Disord; 2003 Jun; 18(6):668-72. PubMed ID: 12784270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microstructure of the non-rapid eye movement sleep electroencephalogram in patients with newly diagnosed Parkinson's disease: effects of dopaminergic treatment.
    Brunner H; Wetter TC; Hogl B; Yassouridis A; Trenkwalder C; Friess E
    Mov Disord; 2002 Sep; 17(5):928-33. PubMed ID: 12360541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of controlled-release levodopa on the microstructure of sleep in Parkinson's disease.
    Wailke S; Herzog J; Witt K; Deuschl G; Volkmann J
    Eur J Neurol; 2011 Apr; 18(4):590-6. PubMed ID: 20849470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients.
    Goetz CG; Wuu J; Curgian L; Leurgans S
    Mov Disord; 2006 Feb; 21(2):267-70. PubMed ID: 16161144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Manifestations of abnormal behavior during REM sleep in all-night polysomnography in patients with Parkinson disease].
    Sonka K; Juklícková M; Hnídková P
    Sb Lek; 2000; 101(4):353-6. PubMed ID: 11702574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hallucinations in Parkinson's disease].
    Moser A; Hagenah J; Kömpf D
    Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of standard carbidopa-levodopa and sustained-release carbidopa-levodopa in Parkinson's disease: pharmacokinetic and quality-of-life measures.
    Pahwa R; Lyons K; McGuire D; Silverstein P; Zwiebel F; Robischon M; Koller WC
    Mov Disord; 1997 Sep; 12(5):677-81. PubMed ID: 9380047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inter-rater reliability for identification of REM sleep in Parkinson's disease.
    Bliwise DL; Willians ML; Irbe D; Ansari FP; Rye DB
    Sleep; 2000 Aug; 23(5):671-6. PubMed ID: 10947035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.